ACADIA Pharmaceuticals's Return On Capital Employed Insights By: Benzinga via Benzinga August 29, 2022 at 09:55 AM EDT According to Benzinga Pro data, during Q2, ACADIA Pharmaceuticals (NASDAQ:ACAD) posted sales of $134.56 million. Earnings were up ... Read More >> Related Stocks: Acadia Pharmaceutica